{
  "paper_metadata": {
    "pmid": "38709234",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 100,
        "demographics": "not specified",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 100,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Functional data provided evidence criteria for 1 of 22 VUS and 6 of 72 variants with conflicting interpretation.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "not specified",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The combined prevalence of germline LP/P variants in BRCA1 and BRCA2 was 1.5%.",
      "key_quotes": [
        "One hundred patients (0.8%) had a germline finding of LP/P in BRCA2."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Only one BRCA2 variant was reported with limited details."
  }
}